Charlotte Charpentier

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)

Véronique Joly, Charles Burdet, Roland Landman et al. · Journal of Antimicrobial Chemotherapy · 2018 · 78 citations

Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses

V. Gounant, Valentine Marie Ferré, Ghassen Soussi et al. · Journal of Thoracic Oncology · 2021 · 62 citations · Full text

Vaccination, Vaccine Development, Immunology +7

Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure

Signe Fransen, Marina Karmochkine, Wei Huang et al. · Antimicrobial Agents and Chemotherapy · 2009 · 47 citations · Full text

Replication Capacity, Human Retrovirus, Integrase Replication Capacity +15

HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study

Charlotte Charpentier, Brigitte Montès, Marine Perrier et al. · Journal of Antimicrobial Chemotherapy · 2017 · 44 citations

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors

Charlotte Charpentier, Didier Laureillard, Christophe Piketty et al. · AIDS · 2010 · 43 citations